Tag: Australian specialty pharmaceutical Company
Mayne Pharma to acquire a portfolio of US generic products from Teva and Allergen
ASX-listed specialty pharmaceutical company Mayne Pharma has entered into a binding agreement to acquire a portfolio of US generic products from Teva and Allergen for...
Featured Article
Don’t get left behind: Manufacturing’s urgent need for digital transformation
As digital transformation reshapes industries worldwide, manufacturers in Australia and beyond are finding themselves at the forefront of an evolution. This shift presents opportunities for companies looking to improve efficiency, drive innovation, and boost growth.
